FDA Approves 'Son of Advair' for COPD ExacerbationsFDA Approves 'Son of Advair' for COPD Exacerbations

Reformulated fluticasone plus vilanterol in combination reduced exacerbations in clinical trials, but pneumonia risk remains a concern. News Alerts
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news